Harrow, Inc.

YTD

ALL

Trade Harrow, Inc. 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About HROW

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.

CEO

Mark L. Baum

CEOMark L. Baum

Employees

382

Employees382

Headquarters

Nashville, Tennessee

HeadquartersNashville, Tennessee

Founded

2006

Founded2006

Employees

382

Employees382

HROW Key Statistics

Market cap

1.40B

Market cap1.40B

Price-Earnings ratio

-126.59

Price-Earnings ratio-126.59

Dividend yield

—

Dividend yield—

Average volume

512.35K

Average volume512.35K

High today

$38.52

High today$38.52

Low today

$37.31

Low today$37.31

Open price

$37.68

Open price$37.68

Volume

128.66K

Volume128.66K

52 Week high

$54.19

52 Week high$54.19

52 Week low

$20.85

52 Week low$20.85

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own HROW. This list is generated using Robinhood data, and it’s not a recommendation.

Rocket Lab Corporation

TransMedics Group

Harrow, Inc.

Trade Harrow, Inc. 24 hours a day, five days a week on Robinhood.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. Show more

HROW Key Statistics

Analyst ratings

100%

People also own

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.